Aller au contenu principal
Profil bibliographique

Motoyasu Kusano

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

273Publications signalées
5878Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Gastroesophageal reflux and treatmentsEosinophilic EsophagitisHelicobacter pylori-related gastroenterology studiesGastrointestinal motility and disordersEsophageal and GI Pathology

Les publications récentes

Accès ouvert 2022 article OpenAlex

Evidence-based clinical practice guidelines for functional dyspepsia 2021

Hiroto Miwa, Akihito Nagahara, Akihiro Asakawa, Makoto Arai et autres

BACKGROUND: Functional dyspepsia (FD) is a disorder that presents with chronic dyspepsia, which is not only very common but also highly affects quality of life of the patients. In Japan, FD became a disease name for national insurance in 2013, and has …

jp (code pays fourni par la source)

136 citations Journal of Gastroenterology
Accès ouvert 2021 article OpenAlex

Impact of improvement of sleep disturbance on symptoms and quality of life in patients with functional dyspepsia

Fumihiko Nakamura, Shiko Kuribayashi, Fumio Tanaka, Noriyuki Kawami et autres

BACKGROUND/AIMS: Functional dyspepsia (FD) is often comorbid with sleep disturbance. However, it is not fully understood how sleep disturbance affects the pathophysiology of FD. We aimed to investigate the relationship between FD and sleep disturbance. METHODS: We prospectively enrolled 20 FD patients …

jp (code pays fourni par la source)

21 citations BMC Gastroenterology
2020 article OpenAlex

Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)

Toshihisa Takeuchi, Takahisa Furuta, Yasuhiro Fujiwara, Mitsushige Sugimoto et autres

BACKGROUND: Vonoprazan (V), a potassium-competitive acid blocker, has a more durable acid-inhibitory effect as compared with standard-dose proton pump inhibitors (PPIs) but has not been compared with 2-4 times higher daily PPI doses administered in two divided doses. AIMS: To evaluate the …

jp, es (code pays fourni par la source)

63 citations Alimentary Pharmacology & Therapeutics

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.